Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case report
Open Access
- 10 January 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Genetics and Metabolism Reports
- Vol. 22, 100555
- https://doi.org/10.1016/j.ymgmr.2019.100555
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Phenylalanine hydroxylase deficiency: diagnosis and management guidelineGenetics in Medicine, 2014
- Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal CharacteristicsPublished by Springer Science and Business Media LLC ,2014
- Influenza-Associated Pediatric Deaths in the United States, 2004–2012PEDIATRICS, 2013
- The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update on Selected TopicsPEDIATRICS, 2013
- Man made disease: Clinical manifestations of low phenylalanine levels in an inadequately treated phenylketonuria patient and mouse studyMolecular Genetics and Metabolism, 2013
- Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changesMolecular Genetics and Metabolism, 2009
- Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled studyThe Lancet, 2007
- The Resource Mothers Study of Maternal Phenylketonuria: Preliminary findingsJournal of Inherited Metabolic Disease, 2004
- The maternal phenylketonuria international study: 1984-20022003
- Maternal Phenylketonuria and HyperphenylalaninemiaThe New England Journal of Medicine, 1980